OPTIMIZING THE VALUE OF STRATEGIC PARTNERSHIPS
Partnering deals and joint ventures among biopharmaceutical and healthcare players are no longer simply opportunistic but are recognized as a strategic imperative. The ever-increasing pressure to hold down healthcare costs is driving companies to adopt strategic partnerships designed to reduce R&D and infrastructure costs, spread risks, and expand access to new technology platforms, assets, and markets. However, getting the most out of these partnerships requires more than a carefully negotiated contract. Achieving success in this increasingly virtualized world also requires unprecedented alignment, coordination, communication, and trust among partners.
BRG works with senior management from both sides of the partnership to establish shared goals, performance measurements, and targets; improve collaboration and communication; and effectively govern the partnership. BRG’s proven strategy management framework and governing process as well as experience and ability in neutral facilitation accelerate the achievement of the full potential of strategic partnerships.